Early toxicity predicts long-term survival in high-grade glioma. - Wikidata - awgldk - TriplyDB

Early toxicity predicts long-term survival in high-grade glioma.

Early toxicity predicts long-term survival in high-grade glioma.

http://www.wikidata.org/entity/Q35006910

about

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.

P2860

Q37396577-0E2BC8E5-8005-42ED-A697-5DA6D0130548 Q38837543-2A827F4F-7C1B-4051-A45D-0C916BFEDAF1 Q48100633-DEC644F7-894C-43A8-AFDC-3503B67B3097 Q52590678-DC858CD8-3AE2-40D1-9CF7-775342E7FB23

P2860

Early toxicity predicts long-term survival in high-grade glioma.

http://www.wikidata.org/entity/Q35006910

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Early toxicity predicts long-term survival in high-grade glioma.

@ast

Early toxicity predicts long-term survival in high-grade glioma.

@en

type

label

Early toxicity predicts long-term survival in high-grade glioma.

@ast

Early toxicity predicts long-term survival in high-grade glioma.

@en

prefLabel

Early toxicity predicts long-term survival in high-grade glioma.

@ast

Early toxicity predicts long-term survival in high-grade glioma.

@en

P1433

Q35006910-10FC3108-7EEF-48A5-BD9D-BAC62980DFB0

P1476

Q35006910-16975D1C-0434-493E-BF2D-F3DADA59155D

P2093

Q35006910-00002AB5-7FDE-4A48-81B3-DA90B5BAE768

Q35006910-17749BF4-3CFD-47F5-9D44-ACC7C3305CC7

Q35006910-394A25AA-BA0B-4C57-81CE-B08E472C85C3

Q35006910-93E1D79D-CC7E-4AFD-A915-1B0CECD417EF

Q35006910-980E5962-AE6E-47F1-9AFF-EE81E034933B

Q35006910-A5B8516D-8DE3-47DF-8EA8-0FF40809A7D4

Q35006910-ACAEE78B-A1D9-4A58-BC4D-2CBBFBDBCF92

Q35006910-D4F0BA04-511A-4276-8CE7-7C2D862B54D2

Q35006910-F5E5C56E-6DB9-4044-8E31-22ED7129C60C

P2860

Q35006910-0C8ED227-95B7-42C5-A52A-53607B0C32CB

Q35006910-1036EF98-09A2-42FE-9FC7-F4324B070467

Q35006910-12A824B4-252F-49F2-A122-8D1DD9DF6147

Q35006910-15AC40F2-6CE4-4B15-B54C-CB357D5AFDAE

Q35006910-26193013-D519-4696-8004-287609DF6C3B

Q35006910-2E6F4A58-2E76-4F32-8BAB-8CF96B6E0C60

Q35006910-300FFE25-4EF2-4B3C-ADC6-C7F1166B958E

Q35006910-4866C29C-24F9-46D6-A399-BAB395AB3F10

Q35006910-4CAE434E-AA12-4401-B0A0-108CE691A49A

Q35006910-50E8939C-489D-4E69-B47E-645C3C520983

P2888

Q35006910-B6FC951F-1F6B-4180-9C78-1D139CA16741

P304

Q35006910-60562C56-A688-4433-A507-3EFF1BE84859

P31

Q35006910-F56C0C63-D861-45F9-B9EA-4A6D7D1898A9

P356

Q35006910-B2ECFBB4-F2F3-4311-90AB-E7BB56631E35

P407

Q35006910-51518C7E-FCB3-45A9-8FF8-A6FC45A97EA2

P433

Q35006910-964A6983-357C-4EE7-938F-C5A505F57FB6

P478

Q35006910-26571C29-004D-4B49-8041-E9F8943D1B6E

P577

Q35006910-14248963-1A9F-4F28-92FF-5E9AC0DB2D38

P5875

Q35006910-6AA295D7-4B46-45AC-978F-5CF27E5F44CD

P6179

Q35006910-90479B3E-930A-4011-AA46-4F3FCDBDE456

P698

Q35006910-C03A2703-4634-4B30-8BAF-AE7A5823062C

P932

Q35006910-ADF79753-FAC2-4BC5-B4E9-FF1D28454767

P356

P1433

British Journal of Cancer

P1476

Early toxicity predicts long-term survival in high-grade glioma.

@en

P2093

A P Dicker

http://www.w3.org/2001/XMLSchema#string

D Andrews

http://www.w3.org/2001/XMLSchema#string

J M Michalski

http://www.w3.org/2001/XMLSchema#string

L Souhami

http://www.w3.org/2001/XMLSchema#string

M Mehta

http://www.w3.org/2001/XMLSchema#string

M Wang

http://www.w3.org/2001/XMLSchema#string

W J Curran

http://www.w3.org/2001/XMLSchema#string

W-Ka Yung

http://www.w3.org/2001/XMLSchema#string

Y R Lawrence

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineli

Neurologic complications of radiation therapy.

Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme.

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.

P2888

P304

1365-1371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2011.123

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51046052

http://www.w3.org/2001/XMLSchema#string

P6179

1020099426

http://www.w3.org/2001/XMLSchema#string

P698

21487410

http://www.w3.org/2001/XMLSchema#string

P932

3101937

http://www.w3.org/2001/XMLSchema#string